A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
GNASR201Cand KRASG12DCooperate to Induce Cystic Pancreatic Lesions
2018
Cancer Discovery
Précis: The SHP2 inhibitor SHP099 increased the antitumor efficacy of MEK inhibition in pancreatic, lung, breast, and ovarian cancer models by preventing MEK inhibitor-induced reactivation of RAS-ERK signaling.
doi:10.1158/2159-8290.cd-rw2018-147
fatcat:fhdspz762nda3ku5otwwqzbypm